Sex as a predictor of response to cancer immunotherapy
Lancet Oncol
.
2018 Aug;19(8):e377.
doi: 10.1016/S1470-2045(18)30517-5.
Authors
Brian Claggett
1
,
Lu Tian
2
,
Zachary R McCaw
3
,
Masahiro Takeuchi
4
,
Lee-Jen Wei
5
Affiliations
1
Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA.
2
Department of Biomedical Data Science, Stanford University School of Medicine, Palo Alto, CA, USA.
3
Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
4
Department of Clinical Medicine (Biostatistics), Kitasato University School of Pharmacy, Tokyo, Japan.
5
Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA. Electronic address:
[email protected]
.
PMID:
30102227
PMCID:
PMC7002025
DOI:
10.1016/S1470-2045(18)30517-5
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Immunotherapy*
Neoplasms*
Grants and funding
R01 HL089778/HL/NHLBI NIH HHS/United States